Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
CanadaIPO:
12 October 2017Website:
http://www.venus.aiNext earnings report:
01 April 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | 12 min agoDividend
Analysts recommendations
Institutional Ownership
VERO Latest News
Venus Concept Inc. (NASDAQ:VERO ) Q3 2024 Earnings Conference Call November 13, 2024 8:00 AM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President and Chief Operating Officer Domenic Della Penna - Executive Vice President and Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Sam Eiber - BTIG Thomas McGovern - Maxim Group Operator Please standby. Good day, ladies and gentlemen, and welcome to the Third Quarter 2024 Earnings Conference Call for Venus Concept Incorporated.
Enhances future international growth profile with new partners and regulatory certifications in key global aesthetic markets Enhances future international growth profile with new partners and regulatory certifications in key global aesthetic markets
TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday, November 13, 2024.
Second Substantial Reduction of Existing Debt by Madryn Asset Management in 2024; the Company has reduced its debt balance by 54% year-to-date Second Substantial Reduction of Existing Debt by Madryn Asset Management in 2024; the Company has reduced its debt balance by 54% year-to-date
The latest approval for Venus Concept in Australia reinforces its position as a global player in the aesthetic technology space.
TORONTO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and six months ended June 30, 2024.
TORONTO, July 15, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2024 financial results will be released before the market opens on Tuesday, August 13, 2024.
Venus Concept (VERO) announces an exclusive strategic supply arrangement with Skin Laundry Holdings, Inc.
TORONTO, June 17, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it has entered a new strategic resurfacing and skin tightening device supply arrangement with Skin Laundry Holdings, Inc. ("Skin Laundry"). The supply arrangement included an initial order for Venus Viva ("Viva") devices for their locations across the United States and the associated Viva tips consumable to complete the procedures. Skin Laundry is placing the devices throughout their chain of clinics and plans to perform thousands of skin resurfacing treatments per month using Venus Concept's proprietary (MP)2 NanoFractional RF Technology with SmartScan, which provides clinically validated efficacy in both resurfacing and tightening. Venus Concept's (MP)2 technology provides both RF and PEMF for optimal collagen and elastin formation with over 9,000 systems installed globally.
Venus Concept (NASDAQ: VERO ) stock is rocketing higher on Friday alongside heavy pre-market trading of the medical technology company's shares this morning. That has more than 6.2 million shares of VERO stock changing hands as of this writing.
What type of business is Venus Concept?
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.
What sector is Venus Concept in?
Venus Concept is in the Healthcare sector
What industry is Venus Concept in?
Venus Concept is in the Medical Devices industry
What country is Venus Concept from?
Venus Concept is headquartered in Canada
When did Venus Concept go public?
Venus Concept initial public offering (IPO) was on 12 October 2017
What is Venus Concept website?
https://www.venus.ai
Is Venus Concept in the S&P 500?
No, Venus Concept is not included in the S&P 500 index
Is Venus Concept in the NASDAQ 100?
No, Venus Concept is not included in the NASDAQ 100 index
Is Venus Concept in the Dow Jones?
No, Venus Concept is not included in the Dow Jones index
When was Venus Concept the previous earnings report?
No data
When does Venus Concept earnings report?
The next expected earnings date for Venus Concept is 01 April 2025